A simple wish to free up time and capacity, and also to share knowledge between Denmark and Norway, is behind biotech group Amgen's decision to join its Danish and Norwegian divisions into one unit with a shared management team, says Tore von Würden, Amgen's country director of Denmark and Iceland, who has been tasked with spearheading the new unit.
"We think there is a lot of development potential in doing this, both for the individual and the individual unit, as we now have the opportunity to free up some energy to share knowledge between the organizations, allowing individual employees to become more skilled and to bring ideas with them to the other market," says von Würden, adding:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.
Stallergenes slapped with injunction
There are still issues with Stallergenes Greer’s factory in Antony, the Agence Nationale de Sécurité du Médicament has concluded.
Overview: Pharma giants and Bavarian Nordic fight over billion-dollar vaccine market
There is currently no approved vaccine for RSV, which causes serious illness and can be deadly for newborns and the elderly. The race to come first to the vaccine market is heating up, while more companies are close to completing phase III studies. Get an overview of their progress here.
Eargo raises USD 100m from investment firm
US-based Eargo, which is run by a Dane, has entered an agreement with an investment firm which is injecting USD 100m into the company.
US authorities expand monkeypox vaccine plan
More Americans will be offered a monkeypox vaccine.
Post Market Surveillance Department Manager 
Global Product Manager - ENT 
Senior Electronics Engineer 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Commercial Market Data Manager 
QA Specialist for Product Equipment Qualification 
Principal Scientist – Pharmacology 
Regulatory Affairs Manager - Maternity Cover 
Training Supporter with high drive 
Senior Toxicologist 
Open position for a Clinical Trial Manager to join our team at Nykode! 
Senior Clinical Trial Disclosure Associate 
Director Regulatory Affairs